Table 1.
Clinical characteristics of included patients, ()/M(Q1, Q3).
| Characteristics | Total cases (n = 209) |
| Age, yrs | 47.53 ± 13.52 |
| Gender, n (%) | |
| Male | 101 (48.33) |
| Female | 108 (51.67) |
| Exposure characteristics, n (%) | |
| Learning or working in Wuhan, China | 4 (4.04) |
| Recent travelling in Wuhan, China | 53 (25.36) |
| Contacting with infected patients | 20 (9.57) |
| Unknown exposure | 47 (22.49) |
| Underlying disease, n (%) | |
| Diabetes mellites | 3 (1.44) |
| Hypertension | 4 (1.91) |
| Cardiovascular and cerebrovascular disease | 3 (1.44) |
| Chronic liver disease | 3 (1.44) |
| Chronic obstructive pulmonary disease | 9 (4.31) |
| Signs and symptoms | |
| Pulse, times/min | 85.58 ± 9.61 |
| Systolic blood pressure, mm Hg | 122.13 ± 10.21 |
| Diastolic blood pressure, mm Hg | 78.56 ± 7.51 |
| Respiratory rate, times/min | 20.00 ± 1.37 |
| Oxygen saturation, % | 69.56 ± 43.78 |
| Body temperature, °C | 37.91 ± 0.78 |
| Fever, n (%) | 179 (85.65) |
| Fatigue, n (%) | 53 (25.36) |
| Cough, n (%) | 128 (61.24) |
| Nasal obstruction, n (%) | 5 (2.39) |
| Running nose, n (%) | 5 (2.39) |
| Sore throat, n (%) | 14 (6.70) |
| Diarrhea, n (%) | 13 (6.22) |
| Headache, n (%) | 22 (10.53) |
| Muscular soreness, n (%) | 26 (12.44) |
| Blood routine test | |
| Hemoglobin, g/L | 134.22 ± 16.10 |
| Red blood cells, 1012/L | 4.38 ± 0.44 |
| White blood cells, 109/L | 4.66 ± 1.59 |
| Platelets, 109/L | 185.24 ± 79.70 |
| Neutrophil count, 109/L | 2.65 (1.9, 3.82) |
| Lymphocyte count, 109/L | 1.29 ± 0.47 |
| Albumin, g/L | 44.08 ± 9.84 |
| Total bilirubin, μmol/L | 9.57 ± 4.86 |
| Serum potassium, mmol/L | 4.04 ± 0.48 |
| Sodium, mmol/L | 138.52 ± 14.38 |
| Coagulation function | |
| Prothrombin time, s | 12.01 ± 5.89 |
| Activated partial thromboplastin time, s | 28.23 ± 8.17 |
| Thrombin time, s | 17.59 ± 1.65 |
| Fibrinogen, g/L | 3.53 ± 1.02 |
| D-dimer, μg/L | 0.32 (0.20, 0.59) |
| Liver function | |
| Alanine aminotransferase, U/L | 24.20 ± 19.34 |
| Aspartate aminotransferase, U/L | 27.83 ± 14.54 |
| Kidney function | |
| Urea nitrogen, mmol/L | 4.56 ± 1.54 |
| Creatinine, μmol/L | 59.30 ± 20.52 |
| Uric acid, μmol/L | 270.85 ± 83.28 |
| Heart function | |
| Lactic dehydrogenase, U/L | 233.56 ± 83.56 |
| α-hydroxybutyrate dehydrogenase, U/L | 181.76 ± 77.45 |
| Creatine kinase, U/L | 63 (39, 104) |
| Creatine kinase-MB, U/L | 9.35 ± 6.23 |
| Blood biochemical indicators | |
| C-reactive protein, μg/L | 10.7 (4.61, 37.7) |
| Erythrocyte sedimentation rate, mm/h | 28.74 ± 21.53 |
| Procalcitonin, μg/L | 0.19 ± 0.13 |
Note: (), mean ± standard deviations; [n(%)] manifested the frequency distribution and its percentage; [M(Q1, Q3)] described as the median (interquartile).